Paula Robinson

1.8k total citations · 1 hit paper
6 papers, 679 citations indexed

About

Paula Robinson is a scholar working on Surgery, Cancer Research and General Health Professions. According to data from OpenAlex, Paula Robinson has authored 6 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Cancer Research and 1 paper in General Health Professions. Recurrent topics in Paula Robinson's work include Cancer, Lipids, and Metabolism (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). Paula Robinson is often cited by papers focused on Cancer, Lipids, and Metabolism (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). Paula Robinson collaborates with scholars based in United States, Australia and United Kingdom. Paula Robinson's co-authors include Christie M. Ballantyne, Narendra D. Lalwani, Harold Bays, Alberico L. Catapano, Kausik K. Ray, LeAnne T. Bloedon, Lulu Ren Sterling, Diane MacDougall, Jeffrey C. Hanselman and Janice R. Margulies and has published in prestigious journals such as New England Journal of Medicine, Circulation and The American Journal of Cardiology.

In The Last Decade

Paula Robinson

6 papers receiving 654 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol

2019 537 citations Kausik K. Ray, Harold Bays et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Paula Robinson

Since Specialization

Citations

This map shows the geographic impact of Paula Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Robinson more than expected).

Fields of papers citing papers by Paula Robinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Robinson. The network helps show where Paula Robinson may publish in the future.

Co-authorship network of co-authors of Paula Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of Paula Robinson. A scholar is included among the top collaborators of Paula Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula Robinson. Paula Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Impact of the COVID‐19 Pandemic on Conduct and Results of CLEAR Outcomes Trial 2024 ·Clinical Cardiology ·(unknown), Luke J. Laffin, Ashish Sarraju, A. Michael Lincoff, Stephen J. Nicholls, LeAnne T. Bloedon, William J. Sasiela, Na Li, Paula Robinson, Stephanie Kelly, (unknown), Steven E. Nissen	2
2	Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study) 2022 ·The American Journal of Cardiology ·Christie M. Ballantyne, Maciej Banach, Harold Bays, Alberico L. Catapano, Ulrich Laufs, Erik S.G. Stroes, Paula Robinson, Lei Lei, Kausik K. Ray	40
3	Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol breakdown → 2019 ·New England Journal of Medicine ·Kausik K. Ray, Harold Bays, Alberico L. Catapano, Narendra D. Lalwani, LeAnne T. Bloedon, Lulu Ren Sterling, Paula Robinson, Christie M. Ballantyne	537
4	Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy 2016 ·The American Journal of Cardiology ·Christie M. Ballantyne, James M. McKenney, Diane MacDougall, Janice R. Margulies, Paula Robinson, Jeffrey C. Hanselman, Narendra D. Lalwani	94
5	Abstract 17499: ETC-1002 Incrementally Lowers Low Density Lipoprotein-cholesterol in Patients With Hypercholesterolemia Receiving Stable Statin Therapy 2015 ·Circulation ·Christie M. Ballantyne, Diane MacDougall, Janice R. Margulies, Paula Robinson, Jeffrey C. Hanselman, Narendra D. Lalwani	4
6	Ten easy ways to manage a project 2000 ·Nursing Standard ·Paula Robinson	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact